Qualitative Assessments of Adherence

  • Michel BurnierEmail author
  • Grégoire Wuerzner
Part of the Updates in Hypertension and Cardiovascular Protection book series (UHCP)


The diagnosis of non-adherence to prescribed medications is a real challenge in clinical medicine. Besides objective methods such as measurements of drug concentrations in plasma or urine and electronic monitoring of adherence, several qualitative approaches are available, which are based on self-report medication adherence scales or specific questionnaires. In a recent systematic review, more than 43 adherence scales have been reported that have been used essentially in chronic diseases including essential hypertension. Although self-reports and questionnaires are considered to have a low reliability to detect a poor medication-taking process, they do provide additional information, which cannot be obtained with objective measures. Thus, adequately validated questionnaires can identify relevant barriers and beliefs to a good medication-taking behavior. Therefore, these approaches should be considered as complementary to the objective measures of adherence and should perhaps not be totally disregarded as they often are.


Self-report scales Questionnaires Morisky medication Behavior Barriers Beliefs 


  1. 1.
    Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organization; 2003.Google Scholar
  2. 2.
    Sokol MC, McGuigan KA, Verbrugge RR, Epstein RS. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43:521–30.CrossRefPubMedGoogle Scholar
  3. 3.
    Corrao G, Parodi A, Nicotra F, Zambon A, Merlino L, Cesana G, Mancia G. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29:610–8.CrossRefPubMedGoogle Scholar
  4. 4.
    Hill MN, Miller NH, DeGeest S, American Society of Hypertension Writing Group. ASH position paper: Adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens (Greenwich). 2010;12:757–64.CrossRefGoogle Scholar
  5. 5.
    Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother. 2004;38:303–12.CrossRefPubMedGoogle Scholar
  6. 6.
    Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19:357–62.CrossRefPubMedGoogle Scholar
  7. 7.
    Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77:427–45.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, Aikens JE, Hunter CM, Velligan DI, Huntley K, Ogedegbe G, Rand CS, Schron E, Nilsen WJ. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5:470–82.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Zeller A, Taegtmeyer A, Martina B, Battegay E, Tschudi P. Physicians’ ability to predict patients’ adherence to antihypertensive medication in primary care. Hypertens Res. 2008;31:1765–71.CrossRefPubMedGoogle Scholar
  10. 10.
    Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97.CrossRefPubMedGoogle Scholar
  11. 11.
    Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86:304–14.CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Straka RJ, Fish JT, Benson SR, Suh JT. Patient self-reporting of compliance does not correspond with electronic monitoring: an evaluation using isosorbide dinitrate as a model drug. Pharmacotherapy. 1997;17:126–32.PubMedGoogle Scholar
  13. 13.
    Wright EC. Non-compliance—or how many aunts has Matilda? Lancet. 1993;342:909–13.CrossRefPubMedGoogle Scholar
  14. 14.
    Davis TME, Strong J, Bloom SR. Compliance in diabetes mellitus: a self-assessment study. Pract Diabetes. 1988;5:170–2.CrossRefGoogle Scholar
  15. 15.
    Fodor GJ, Kotrec M, Bacskai K, Dorner T, Lietava J, Sonkodi S, Rieder A, Turton P. Is interview a reliable method to verify the compliance with antihypertensive therapy? An international central-European study. J Hypertens. 2005;23(6):1261.CrossRefPubMedGoogle Scholar
  16. 16.
    Perez-Escamilla B, Franco-Trigo L, Moullin JC, Martinez-Martinez F, Garcia-Corpas JP. Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Prefer Adherence. 2015;9:569–78.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67–74.CrossRefPubMedGoogle Scholar
  18. 18.
    Schroeder K, Fahey T, Hay AD, Montgomery A, Peters TJ. Adherence to antihypertensive medication assessed by self-report was associated with electronic monitoring compliance. J Clin Epidemiol. 2006;59:650–1.CrossRefPubMedGoogle Scholar
  19. 19.
    Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ. Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure. Clin Ther. 2000;22:858–71.CrossRefPubMedGoogle Scholar
  20. 20.
    Svarstad BL, Chewning BA, Sleath BL, Claesson C. The Brief Medication Questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns. 1999;37:113–24.CrossRefPubMedGoogle Scholar
  21. 21.
    Kim MT, Hill MN, Bone LR, Levine DM. Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog Cardiovasc Nurs. 2000;15:90–6.CrossRefPubMedGoogle Scholar
  22. 22.
    Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.CrossRefGoogle Scholar
  23. 23.
    Culig J, Leppee M. From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll Antropol. 2014;38:55–62.PubMedGoogle Scholar
  24. 24.
    Hamilton GA. Measuring adherence in a hypertension clinical trial. Eur J Cardiovasc Nurs. 2003;2:219–28.CrossRefPubMedGoogle Scholar
  25. 25.
    Shi L, Liu J, Fonseca V, Walker P, Kalsekar A, Pawaskar M. Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual Life Outcomes. 2010;8:99.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lambert EV, Steyn K, Stender S, Everage N, Fourie JM, Hill M. Cross-cultural validation of the hill-bone compliance to high blood pressure therapy scale in a South African, primary healthcare setting. Ethn Dis. 2006;16:286–91.PubMedGoogle Scholar
  27. 27.
    Koschack J, Marx G, Schnakenberg J, Kochen MM, Himmel W. Comparison of two self-rating instruments for medication adherence assessment in hypertension revealed insufficient psychometric properties. J Clin Epidemiol. 2010;63:299–306.CrossRefPubMedGoogle Scholar
  28. 28.
    Karademir M, Koseoglu IH, Vatansever K, Van Den Akker M. Validity and reliability of the Turkish version of the Hill-Bone compliance to high blood pressure therapy scale for use in primary health care settings. Eur J Gen Pract. 2009;15:207–11.CrossRefPubMedGoogle Scholar
  29. 29.
    Zeller A, Schroeder K, Peters TJ. An adherence self-report questionnaire facilitated the differentiation between nonadherence and nonresponse to antihypertensive treatment. J Clin Epidemiol. 2008;61:282–8.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of MedicineService of Nephrology and Hypertension, Centre Hospitalier Universitaire VaudoisLausanneSwitzerland

Personalised recommendations